leadf
logo-loader
viewSativa Wellnesss Group Inc

Sativa Investments teams up with King's College London to research cannabinoids for medicinal use

Sativa will supply the university with specific strains of cannabis plants that contain various combinations of the spectrum of at least 113 known cannabinoids

cannabis
Sativa is the UK's first medicinal cannabis investment vehicle

UK medicinal cannabis investor Sativa Investments PLC (AQSE: SATI) has teamed up with King's College London to research the impact of cannabinoids on inflammation and respiratory diseases. 

Under the research agreement, Sativa will supply the university with specific strains of cannabis plants that contain various combinations of the spectrum of at least 113 known cannabinoids, subject to regulatory approval.

READ: Sativa Investments completes 1000th cannabinoid and terpenes test at PhytoVista facility

Sativa will provide the service through investee business, Canada-based Veritas Pharma Inc, and its own on-site testing facility, PhytoVista Laboratories.

Professor Clive Page OBE PhD Professor of Pharmacology at King's College London will lead the research.

"With the UK catching up fast in terms of recognising the benefits of medicinal cannabis, in-country research from the globally-recognised King's College London will assist the medical profession, Government and Regulators in their deliberations,” said Sativa founder and chief executive, Geremy Thomas.

"As the UK's first medicinal cannabis investment vehicle, Sativa remains at the forefront of this fast-developing sector, which effectively mirrors what has been happening in North America since medicinal cannabis was first legalised in Canada in 2001, more than 17 years ago.”

Quick facts: Sativa Wellnesss Group Inc

Price: 2.35 GBX

AQSE:SATI
Market: AQSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Wellnesss Group Inc named herein, including the promotion by the Company of Sativa Wellnesss Group Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Sativa Group PLC signs LOI with Stillcanna to become part of the company

  Sativa Group PLC (AQSE: SATI) CEO Henry Lees-Buckley joined Steve Darling from Proactive to discuss the company signing a letter of intent with Stillcanna for the companies to come together as one. Lees-Buckley discusses the reason behind this move and what it does for them in...

on 11/6/20

2 min read